{"id":"cvt-e002-ginseng-extract","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL4303226","moleculeType":"Small molecule","molecularWeight":"465.48"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action of CVT-E002 ginseng extract is not fully understood, but it is thought to work by reducing inflammation and improving blood flow through its antioxidant and anti-inflammatory properties. This may help to improve cardiovascular health and reduce the risk of heart disease.","oneSentence":"CVT-E002 ginseng extract is an herbal supplement that may help improve cardiovascular health by reducing inflammation and improving blood flow.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:09:26.903Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT00752895","phase":"PHASE2","title":"American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2008-09-01","conditions":"Leukemia","enrollment":293},{"nctId":"NCT00965822","phase":"PHASE2","title":"A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population","status":"COMPLETED","sponsor":"Afexa Life Sciences Inc","startDate":"2009-09","conditions":"Upper Respiratory Tract Infections","enrollment":293},{"nctId":"NCT00255307","phase":"PHASE2","title":"Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.","status":"COMPLETED","sponsor":"CV Technologies","startDate":"2005-11","conditions":"Upper Respiratory Infection","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CVT-E002 ginseng extract","genericName":"CVT-E002 ginseng extract","companyName":"CV Technologies","companyId":"cv-technologies","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CVT-E002 ginseng extract is an herbal supplement that may help improve cardiovascular health by reducing inflammation and improving blood flow. Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}